Wow...nice find.
About ROCHE...
Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas.
One particularly important area where we are placing our Partnering efforts is in Neuroscience. We believe the field of Neuroscience is on the cusp of important breakthroughs in both early diagnosis and treatment. Our relentless pursuit of scientific innovation is taking us into areas of enormous unmet medical need and progress in treating diseases of the brain and nervous system.
Our collaborative efforts have resulted in one of the strongest and most diverse pipelines in the industry, spanning the spectrum of nervous system disorders from the rarest to the most common.
Partnering opportunities we are looking for:
Neurodegenerative diseases (e.g. Alzheimer's disease, Parkinson's disease, Huntington disease)
Neuroimmunology and neuroinflammation (e.g. Multiple sclerosis)
Neurodevelopment and psychiatry (e.g. Angelman Syndrome, Schizophrenia, and Autism spectrum disorders)
Neuromuscular diseases (e.g. SMA and Duchenne Muscular Dystrophy)
News 
Market Data 
Discover 
AI
